Latest research study from Market Research
Future with title “Neurocutaneous Disorder Market” by Top Regions, Type and Application. The
Research report presents a complete overview of the market and contains Future
trend, Current Growth Factors, historical data. - Forecast till 2023.
Neurocutaneous
Disorder Market Scenario:
Increasing government initiatives for ensuring the
early diagnosis is supposed to be a significant driver of the market. Moreover,
many guidelines are issued by government organizations to promote awareness
related to effective prevention measures, globally. All these factors are
expected to contribute to the market growth throughout the forecast period.
Tuberous sclerosis (TS) is a non-cancerous growth that
occurs in organs such as brain, eyes, kidneys, heart, lungs, bones, and skin.
There is a 50% chance of children to develop TS if the parent is affected by
it. Moreover, the Sturge-Weber Syndrome (SWS) causes malformations relating to
the face, eye, and brain. It is estimated that about 1 in 20,000 to 50,000 live
births may be affected with the Sturge-Weber syndrome.
Neurocutaneous
Disorder Market Key
Players:
Some of the key players in the global neurocutaneous
disorder market are Valeant Pharmaceuticals International, Inc. (U.S.),
Allergan (U.S.), Syneron Medical Ltd (U.S.), Medtronic Plc (U.S.), Cutera, Inc.
(U.S.), St Jude Medical, Inc. (U.S.), Pfizer Inc. (U.S.), Novartis AG
(Switzerland), Abbott Laboratories Inc. (U.S.), UCB S.A. (Belgium), Sanofi SA
(France), Shire Plc (Ireland), F. Hoffmann-La Roche AG (Switzerland),
Aleva Neurotherapeutics SA (Switzerland), Johnson & Johnson (U.S.), and others.
Neurocutaneous
Disorder Market Segmentation:
The global neurocutaneous disorder market has been
segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the global neurocutaneous
disorder market can be segmented into Tuberous Sclerosis (TS),
Neurofibromatosis (NF), Sturge-weber syndrome disease, Ataxia-Telangiectasia
(A-T), Von Hippel-Lindau disease (VHL), and others.
On the basis of diagnosis, the global neurocutaneous
disorder market can be segmented into skull radiography, Magnetic Resonance
Imaging (MRI), Computed Tomography (CT) scan, Electroencephalogram (EEG),
genetic tests (blood testing), biopsy, and others.
On the basis of treatment, the global neurocutaneous
disorder market can be segmented into medication, laser therapy, surgical
procedures, and others.
On the basis of end-user, the global neurocutaneous
disorder market is segmented into hospitals and clinics, diagnostic centers,
and others.
Neurocutaneous
Disorder Market Intended
Audience:
Clinical and diagnostic labs
Pharmaceutical and biotechnology companies
Regulatory bodies
Medical device companies
Healthcare providers
Research and consulting firms
Venture capitalists and investors
Neurocutaneous
Disorder Market Regional
Analysis:
The global neurocutaneous disorder market consists of
four regions, namely, the Americas, Europe, Asia Pacific, and the Middle East
and Africa.
The Americas region accounted for the largest market
share of the global neurocutaneous disorder market owing to the increasing
awareness about genetic disorders along with the growing number of drug and
medical service providers. As per the National Institute of Neurological
Disorders and Stroke (NINDS) in 2017, Neurofibromatosis Type 1 (NF1) occurs in
about 1 in 3,000 to 4,000 births in the U.S. This condition is a chromosomal
disorder which is inherited from a parent. Moreover, Neurofibromatosis Type 2
(NF2) occurs less frequently, affecting about 1 in 25,000 births in the U.S.
The European neurocutaneous disorder market is the
second largest market followed by Asia Pacific. The Asia Pacific region is
expected to exhibit the fastest growth throughout the forecast period owing to
the exceptional healthcare standards and infrastructure, rising healthcare
expenditure, and growing presence of outsourcing organizations across this
region.
The Middle Eastern region is expected to grow at a steady
pace owing to factors such as the extensive development of the healthcare
infrastructure and increasing R&D activities in the healthcare sector.
Table
Of Contents
Chapter
1. Report Prologue
Chapter
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
TOC
Continued……!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@Marketresearchfuture.com
